NEW YORK, June 4, 2015 /PRNewswire/ -- S&P
SmallCap 600 constituent Manhattan Associates Inc. (NASD:
MANH) will replace Life Time
Fitness Inc. (NYSE: LTM) in the S&P MidCap 400, and Supernus
Pharmaceuticals Inc. (NASD: SUPN) will replace Manhattan Associates
in the S&P SmallCap 600 after the close of trading on
Wednesday, June 10. Affiliates of
private equity firms Leonard Green
& Partners and TPG Capital L.P. are acquiring Life Time Fitness
in a deal expected to be completed on or about that date pending
final approvals.
Manhattan Associates develops, sells, deploys, services, and
maintains software solutions to manage supply chains, inventory,
and omni-channel operations. Headquartered in Atlanta, GA, the company will be added to the
S&P MidCap 400 GICS (Global Industry Classification Standard)
Application Software Sub-Industry index.
Supernus Pharmaceuticals is a specialty pharmaceutical company.
Headquartered in Rockville, MD,
the company will be added to the S&P SmallCap 600 GICS
Pharmaceuticals Sub-Industry index.
Following is a summary of the changes:
|
S&P MIDCAP 400
INDEX – June 10, 2015
|
|
COMPANY
|
GICS ECONOMIC
SECTOR
|
GICS
SUB-INDUSTRY
|
|
ADDED
|
Manhattan
Associates
|
Information
Technology
|
Application
Software
|
|
DELETED
|
Life Time
Fitness
|
Consumer
Discretionary
|
Leisure
Facilities
|
|
S&P SMALLCAP
600 INDEX – June 10, 2015
|
|
COMPANY
|
GICS ECONOMIC
SECTOR
|
GICS
SUB-INDUSTRY
|
|
ADDED
|
Supernus
Pharmaceuticals
|
Health
Care
|
Pharmaceuticals
|
|
DELETED
|
Manhattan
Associates
|
Information
Technology
|
Application
Software
|
Additions to and deletions from S&P Dow Jones Indices
do not in any way reflect an opinion on the investment merits of
the companies involved.
About S&P Dow Jones Indices
S&P Dow Jones Indices LLC, a part of McGraw Hill Financial,
is the world's largest, global resource for index-based concepts,
data and research. Home to iconic financial market indicators, such
as the S&P 500® and the Dow Jones Industrial Average®, S&P
Dow Jones Indices LLC has over 115 years of experience constructing
innovative and transparent solutions that fulfill the needs of
investors. More assets are invested in products based upon our
indices than any other provider in the world. With over 1,000,000
indices covering a wide range of asset classes across the globe,
S&P Dow Jones Indices LLC defines the way investors measure and
trade the markets. To learn more about our company, please visit
www.spdji.com.
S&P® is a registered trademark of Standard & Poor's
Financial Services LLC ("S&P"), a part of McGraw Hill
Financial. Dow Jones® is a registered trademark of Dow Jones
Trademark Holdings LLC ("Dow Jones"). These trademarks have
been licensed to S&P Dow Jones Indices LLC. It is not possible
to invest directly in an index. S&P Dow Jones Indices LLC, Dow
Jones, S&P and their respective affiliates (collectively
"S&P Dow Jones Indices") do not sponsor, endorse, sell, or
promote any investment fund or other investment vehicle that is
offered by third parties and that seeks to provide an investment
return based on the performance of any index. This document does
not constitute an offer of services in jurisdictions where S&P
Dow Jones Indices does not have the necessary licenses. S&P Dow
Jones Indices receives compensation in connection with licensing
its indices to third parties.
For more information:
David Blitzer
Managing Director and Chairman of the Index Committee
S&P Dow Jones Indices
(+1) 212 438 3907
david.blitzer@spdji.com
David R. Guarino
Communications
S&P Dow Jones Indices
(+1) 212 438 1471
dave.guarino@spdji.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/manhattan-associates-set-to-join-the-sp-midcap-400-supernus-pharmaceuticals-to-be-added-to-the-sp-smallcap-600-300094605.html
SOURCE S&P Dow Jones Indices